🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of Tylenol, asserting the companies withheld alleged dangers that the drug posed to pediatric neurological development.

The court filing comes a month after President Donald Trump promoted an unproven link between taking Tylenol - alternatively called paracetamol - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against the pharmaceutical giant, which once produced the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by profiting off of suffering and marketing drugs without regard for the potential hazards."

Kenvue says there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, stated.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its online platform, the company also said it had "continuously evaluated the applicable studies and there is no credible data that indicates a proven link between using acetaminophen and autism."

Associations representing physicians and healthcare providers agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the main ingredient in Tylenol - is among limited choices for pregnant women to manage pain and fever, which can create major wellness concerns if not addressed.

"In over twenty years of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has successfully concluded that the usage of acetaminophen in any trimester of pregnancy leads to neurodevelopmental disorders in children," the organization stated.

The lawsuit cites current declarations from the Trump administration in arguing the drug is reportedly hazardous.

In recent weeks, Trump raised alarms from public health officials when he instructed expectant mothers to "struggle intensely" not to take acetaminophen when unwell.

The US Food and Drug Administration then issued a notice that doctors should contemplate reducing the use of Tylenol, while also declaring that "a proven link" between the drug and autism in children has remains unverified.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to conduct "comprehensive study program" that would establish the cause of autism spectrum disorder in a short period.

But specialists advised that finding a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of inherited and external influences - would prove challenging.

Autism is a form of enduring cognitive variation and disability that impacts how persons encounter and relate to the environment, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is campaigning for federal office - alleges the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action attempts to require the corporations "eliminate any commercial messaging" that states Tylenol is reliable for expectant mothers.

This legal action mirrors the complaints of a collection of guardians of children with autism and ADHD who took legal action against the producers of Tylenol in recently.

Judicial authorities dismissed the lawsuit, declaring investigations from the parents' expert witnesses was inconclusive.